Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes

M.C.M. Bunck; A. Corner; B. Eliasson; R.J. Heine; R.M. Shaginian; M.R. Taskinen; U. Smith; H. Yki-Jarvinen; M. Diamant

Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes

M.C.M. Bunck
, A. Corner
, B. Eliasson
, R.J. Heine
, R.M. Shaginian
, M.R. Taskinen
, U. Smith
, H. Yki-Jarvinen
, M. Diamant

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	Undefined/Unknown
Pages (from-to)	848
Journal	Diabetologia
Volume	53
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{654caf98d8f1489dbbe8999b373c5e86,

title = "Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes",

author = "M.C.M. Bunck and A. Corner and B. Eliasson and R.J. Heine and R.M. Shaginian and M.R. Taskinen and U. Smith and H. Yki-Jarvinen and M. Diamant",

year = "2010",

language = "Undefined/Unknown",

volume = "53",

pages = "848",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes

AU - Bunck, M.C.M.

AU - Corner, A.

AU - Eliasson, B.

AU - Heine, R.J.

AU - Shaginian, R.M.

AU - Taskinen, M.R.

AU - Smith, U.

AU - Yki-Jarvinen, H.

AU - Diamant, M.

PY - 2010

Y1 - 2010

M3 - Meeting Abstract

SN - 0012-186X

VL - 53

SP - 848

JO - Diabetologia

JF - Diabetologia

ER -